HYPOTHALAMIC NONAPEPTIDE AND CARCINOGENESIS: DISCUSSION QUESTIONS
https://doi.org/10.20340/mv-mn.2015.0(1):97-105
Abstract
The paper used literature data on the impact of hypothalamic nonapeptide oxytocin in particular for tumor growth and metastasis.
About the Author
O. N. Tomchuk
ГБОУ ВПО «Оренбургский государственный медицинский университет» Минздрава России
Russian Federation
Russian Federation
References
1. Стадников А.А. Фундаментальные и прикладные аспекты нейроэндокринной регуляции взаимодействий про- и эукариот/А.А. Стадников, Л.В. Ковбык, О.Л. Карташова // Известия Челябинского научного центра. - 2001. - № 4 (13). - С. 88-91.
2. Стадников А.А. О влиянии факторов супраоптических и паравентрикулярных ядер гипоталамуса на рост, клеточную репродукцию и цитодифференцировку эпителия аденогипофиза / А.А. Стадников, А.Л. Поленов // Российский физиологический журнал им. И.М. Сеченова. - 1997. - Т. 83, № 8. - С. 65-73.
3. Стадников А.А. Фундаментальные и прикладные аспекты нейроэндокринной регуляции взаимодействий про- и эукариот/А.А. Стадников, Л.В. Ковбык, О.Л. Карташова //Известия Челябинского научного центра. -2001. -№4. - С 88-91.
4. Григорьева М. Е. Окситоцин: строение, синтез, рецепторы и основные эффекты / М. Е. Григорьева, М. Г. Голубева // Нейрохимия. - 2010. - №2. - С. 93-101.
5. Gimpl G. The oxytocin receptor system: structure, function, and regulation /G. Gimpl, F. Fahrenholz// Physiological Reviews. - 2001. - V. 81. - Р. 629-683.
6. Стадников А.А., Бухарин О.В. Гипоталамическая нейросекреция и структурно-функциональный гомеостаз про- и эукариот (Морфологические основы реактивности, пластичности и регенера-ции)/А.А. Стадников, О.В. Бухарин. - Оренбург: ОрГМА, 2012. - 296 с.
7. Стадников А.А. Роль гипоталамических нейропептидов во взаимодействиях про- и эукариот: структурно-функциональные аспекты. /А.А. Стадников. - Екатеринбург: УрО РАН, 2001. - 243 с.
8. Gimpl G. The oxytocin receptor system: structure, function, and regulation/G. Gimpl, F. Fahrenholz// Physiol. Rev. - 2001. - V. 81. - Р. 629-683.
9. Donaldson Z.R. Oxytocin, vasopressin, and the neurogenetics of sociality / Z.R. Donaldson, L. J. Youn // Science. - 2008. - V. 322. - № 7. - P. 900-904.
10. Смирнов А.Н. Элементы эндокринной регуляции. /А.Н. Смирнов. - М.: ГЭОТАР-Медиа, 2006. - 351 с.
11. Ivell R. The structure and regulation of the oxytocin receptor/ R. Ivell, T. Kimura, D. Muller, K. Augustin, N. Abend, R. Bathgate, R. Telgmann, M. Balvers// Exp. Physiol. - 2001. - V. 86. - № 2. - P. 289-296.
12. Kimura T. Structure and expression of a human oxytocin receptor / Kimura T. O., Tanizawa, K. Mori, M.J. Brownstein, H. Okayama//Nature. - 1992. - V. 356. - P. 526-529.
13. Arias F. Pharmacology of oxytocin and prostaglandins / F. Arias // Clin Obstetric and Gynecology. - 2000. - V. 43. - № 3. - P. 455-468.
14. Huang W. Sodium excretion and renin secretion after continuous versus pulsatile infusion of oxytocin in rats / W. Huang, E. Jacobson, O. Skott, E.M. Stricker, A.F. Sved // J. Endocrinol. - 1999. - V. 140. - N 6. - P. 2814- 2818.
15. Мельников А.П. Окситоцин: современные представления о механизме действия и клиническом использовании /А.П. Мельников, В.А. Петрухин, В.А. Колесникова, Б.А. Слободянюк // Российский вестник акушера-гинеколога. - 2009. - №. 3. - С. 19-26.
16. Terzidou V. Labor and Inflammation Increase the Expression of Oxytocin Receptor in Human Amnion / V. Terzidou, A.M. Blanks, S.H. Kim//Biol. Reprod. - 2011. - V. 84. - Р. 546-552.
17. Viero C. Oxytocin: Crossing the bridge between basic science and pharmacotherapy CNS / C. Viero, I. Shibuya, N. Kitamura // Neuroscience & Therapeutics. - 2010. - V. 16. - № 5. - Р. 138-156.
18. Whittington K. Function and localization of oxytocin receptors in the reproductive tissue of rams / K. Whittington, S.J. Assinder, T. Parkinson // Reproduction. - 2001. - V. 122. - Р. 317-325.
19. Зинчкеконко В.П. Внутриклеточная сигнализация. / В.П. Зинчкеконко, Зинчкеконко, Л.П., Долгачева. Пущино: Аналитическая микроскопия, 2003. 84 c.
20. Филлипов П.П. Как внешние сигналы передаются внутри клетки / П.П. Филлипов // Соросовский образовательный журнал. - 1998. - №3. - С. 28-34.
21. Кукес Ф.Г. Рецепторы в клинической фармакологии / Ф.Г. Кукес, В.П. Фисенко // Пособие для студентов медицинских ВУЗов, аспирантов и практических врачей. М.: Палея-М, 2001. 162с.
22. Тепляшина Е.А. Роль окситоцина и окситоциновых рецепторов в регуляции репродуктивных функций и фолликулогенеза / Е.А. Тепляшина, О.Л. Лопатина, М.В. Екимова, Е.А. Пожиленкова, А.Б.Салмина // Сибирский медицинский журнал. - 2013. - №6. С. 21-25.
23. Тепляшина Е.А. Роль окситоцина и окситоциновых рецепторов в регуляции репродуктивных функций и фолликулогенеза / Е.А. Тепляшина, О.Л. Лопатина, М. В. Екимова, Е.А. Пожиленкова, А.Б. Салмина //Сибирский медицинский журнал. - 2013. - № 8. - С. 21-26.
24. Voss A.K. Oxytocin secretion by bovine granulosa cells: effects of stage follicular development, gonadotropins, and coculture with theca interna / A.K. Voss, J.E. Fortune//Endocrinology. - 1991. -Vol. 128. - P. 1991-1999.
25. Devost D. Oxytocin-induced activation of eukaryotic elongation factor 2 in myometrial cells is mediated by protein kinase C / D. Devost, M. Carrier, H. Zingg // Endocrinology. - 2008. - V. 149. - Р.131-138.
26. Rimoldi V. Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains / V. Rimoldi, A. Reversi, E. Taverna, //Oncogene. - 2003. - V. 22. - Р. 6054-6060.
27. Thibonnier M. Human vascular endothelial cells express oxytocin receptors / M. Thibonnier, D.M. Conarty, J.A. Preston, C.L. Plesnicher, R.A. Dweik, S.C. Ersurum // Endocrinology. - 1999. - V. 140. - Р. 1301.
28. Jankowski M. Oxytocin and its receptors are synthesized in the rat vasculature/M. Jankowski, D. Wang, F. Hajjar, S. Mukaddam-Daher, S.M. McCann, J. Gutkowska //Proc. Natl. Acad. Sci. USA. - 2000. - V. 97. - Р. 6207-6211.
29. Svanstrom M.C. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during / M.C. Svanstrom, B. Biber, M. Hanes, G. Johansson, U. Naslund, E. M. Balfors // Br. J. Anesthesia. - 2008. - V. 100. - №5. - P. 683-689.
30. Taylor A.H. Interaction of vasopressin and oxytocin with human breast carcinoma cells./A.H. Taylor, V.T. Ang, J.S. Jenkins, J.J. Silverlight, R.C. Coombes, Y.A. Luqmani //Cancer Res. - 1990. - №50. - Р. 7882- 7886.
31. Cassoni P. Oxytocin in- hibits proliferation of human breast cancer cell lines. / P. Cassoni, A. Sapino, F. Negro, G. Bussolati// Virchows Arch. -1994. - № 425.- P. 467-72.
32. Gutkowska J. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart./ J. Gutkowska, M. Jankowski, C. Lambert, D.S. Mukaddam, H.H. Zingg, Mc S.M. Cann//Proc. Natl. Acad. Sci. USA. - 1997. - V. 94. - Р. 11 704-11 709.
33. Douglas A.J. Quo vadis neurohypophysial hormone research?/A.J. Douglas, M. Ludwig// Exp. Physiol. - 2000. - V. 85. - P. 267-272.
34. Kimura T., Saji F., Nishimori K., Ogita K., Nakamura H., Koyama M., Murata Y. Molecular regulation of the oxytocin receptor in peripheral organs/ T. Kimura, F. Saji, K. Nishimori, K. Ogita, H. Nakamura, M. Koyama, Y. Murata // J. Molecular Endocrinol. - 2003. - V. 30. - № 2. - P. 109-115.
35. Arpin-Bott M.P Historadioautographic localization of oxytocin and V1a vasopressin binding sites in the kidney of developing and adult rabbit, mouse and merione and of adult human / M.P. Arpin-Bott, B. Kaissling, E. Waltisperger, M. Rahin, P. Saussine, M.J. Freund-Mercier, M.E. Stoeckel// Exp. Nephrol. - 2002. - V. 10. - № 3. - Р. 196-208.
36. Copland A.J. Functional oxytocin receptors discovered in human osteoblasts/A.J. Copland, K.L. Ives, D.J. Simmons, M.S. Soloff//J. Endocrinol. - 1999. - V. 140. - Р. 4371-4375.
37. Cassioni P. Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance / P. Cassioni, E. Fulcheri, M.L. Carcangiu, A. Stella, S. Deaglino, G. Bussolati // J. Pathol. - 2000. - V. 190. - P. 470- 477.
38. Cassoni P. Oxytocin induces proliferation and migration in immortalized human dermal microvascular endothelial cells and human breast tumor-derived endothelial cells / P. Cassoni, T. Marrocco, B. Bussolati, E. Allia, I. Munaron, A. Sapino, A. Bussolati//Molecul. Cancer Res. - 2006. - № 4. - Р. 351-359.
39. Голубева М.Г. Участие адренорецепторов в реакциях системы гемостаза на введение дез-глицил-амид-аргинил-вазопрессина./М.Г. Голубева, Т.М. Калишевская, М.Е. Соловьева //Вестн. МГУ. Сер. биол. -1999. - Т. 36. - № 3. - С. 25-30.
40. Russell J.A. Sex, parturition and motherhood without oxytocin? / J.A. Russell, G. Leng // J. Endocrinol. - 1998. - V. 75. - P. 343-359.
41. Фролов Б.А. Физиология и патология нейроэндокринной регуляции. / Б.А. Фролов - М.: Медицина, 2006. 320 с.
42. Nishimori K. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. / K. Nishimori, L.J. Young, Q. Guo, Z. Wang, T.R. Insel, M.M. Matzuk// Proc Natl Acad Sci USA. - 1996. - № 93. - Р. 11699-11704.
43. Olins G.M. Oxytocin-stimulated myosin phosphorylation in mammary myoepithelial cells: roles of calcium ions and cyclic nucleotides. / G.M. Olins, R.D. Bremel // Endocrinology. - 1984. - № 114. - Р. 1617-1626.
44. Cassoni P. Oxytocin synthesis within the normal and neoplastic breast: First evidence of a local peptide source/P. Cassoni, T. Marrocco, A. Sapino, E. Allia, G.Bussolati // International journal of oncology. - 2006. - № 28. - P. 1263-1268.
45. Ширшев С.В. Механизмы действия белково-пептидных гормонов, катехоламинов и простагландинов (глава 2.2)/С.В. Ширшев//Механизмы иммуноэндокринного контроля процессов репродукции. Екатеринбург: УрО РАН, 2002. - Т.1. - С.161-202.
46. Лебедев В. Ф. Иммунотерапия рекомбинантным интерлейкином-2 тяжелых ранений и травм / В. Ф. Лебедев, В. К. Козлов, С. В. Гаврилин [и др.]. - СПб. : Изд-во Санкт- Петерб. ун-та. - 2002. - 72 с.
47. Самотруева М.А. Пути реализации нейро-иммуно-эндокринных взаимодействий/М.А. Самотруева, Д.Л. Теплый, И.Н. Тюренков//Естественные науки. - 2009. - № 4. - С. 112-130.
48. Cassoni P. Oxytocin is a growth factor for Kaposi’s sarcoma cells: evidence of endocrine-immunological cross-talk. / P. Cassoni, A. Sapino, S. Deaglio, B. Bussolati, M. Volante, L. Munaron, A. Albini, A. Torrisi, G. Bussolati//Res. - 2002. - № 62. - P. 2406-2413.
49. Rauk P. N. Interleukin-1β down-regulates the oxytocin receptor in cultured uterine smooth muscle cells. / P.N. Rauk, U. Friebe-Hoffman // Am. J. Reprod. Immunol. - 2000. - № 43. - P. 85-91.
50. Schmid B. Transcriptional regulation of oxytocin receptor by interleukin-1ß and interleukin-6. / B. Schmid, S. Wong, B.F. Mitchell // Endocrinology. - 2001. - №142. - P. 1380-1385.
51. Cassoni P. Oxytocin inhibits proliferation of human breast cancer cell lines. / P. Cassoni, A. Sapino, F. Negro, G. Bussolati// Virchows Arch - 1994. - № 425. Р. - 467-472.
52. Cassoni P. Oxytocin and oxytocin-analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas. / P. Cassoni, A. Sapino, M. Papotti, G. Bussolati // Int J Cancer. - 1996. - № 66. - P. 817-820.
53. Cassoni P. Oxytocin synthesis within the normal and neoplastic breast: First evidence of a local peptide source / P. Cassoni, T. Marrocco, A. Sapino, E. Allia, G. Bussolati // international journal of oncology. - 2006. -№ 28. - P. 1263-1268.
54. Péqueux C. Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through autocrine/paracrine signaling. / C. Pequeux, C. Breton, J.C. Hendrick, M.T. Hagelstein, H. Martens, R. Winkler, V. Geenen, J.J. Legros // Cancer Res. - 2002. - №62. - P. 4623-4629.
55. Tahara A. Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells. / A. Tahara, J. Tsukada, Y. Tomura, K. Wada, T. Kusayama, N. Ishii, T. Yatsu, W. Uchida, A. Tanaka // Br J Pharmacol. - 2000. - № 129. - P. 131-139.
56. Lucas R.L. Astroglia proliferate in response to oxytocin and vasopressin. /R.L. Lucas, A.K. Salm// Brain Res - 1995. - № 681. - P. 218-222.
57. Petersson M. Oxytocin stimulates proliferation of human osteoblast-like cells. / M. Petersson, A. Lagumdzija, A. Stark, E. Bucht// Peptides. - 2002. - № 23. - P. 1121-1126.
58. Ito Y. Investigation of the oxytocin receptor expression in human breast cancer tissue using newly established monoclonal antibodies. / Y. Ito, T. Kobayashi, T. Kimura, N. Matsuura, E. Wakasugi, T. Takeda, T. Shimano, Y. Kubota, T. Nobunaga, Y. Makino, C. Azuma, F. Saji, M. Monden //Endocrinology. - 1996. -№ 137. - P. 773-779.
59. Fay M.J. Oxytocin does not induce a rise in intracellular free calcium in human breast cancer cells. / M.J. Fay, K.A. Longo, W.G. North // Res Comun Mol Pathol Pharmacol. - 1999. - № 103. - P. 115-128.
60. Amico J.A. Estradiol and progesterone regulate oxytocin receptor binding and expression in human breast cancer cell lines./J.A. Amico, P.N. Rauk, H.M. Cai // Endocrine. - 2002. - № 18. - P. 79-84.
61. Cassoni P. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors. /P. Cassoni, A. Sapino, N. Fortunati, G. Bussolati// Int J Cancer. - 1998. - № 77. -695-700.
62. Cassoni P. Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adenosine monophosphate and protein kinase A. / P. Cassoni, A. Sapino, N. Fortunati, L. Munaron, B. Chini, G. Bussolati// Int J Cancer. - 1997. - V. 72. - P. 340-344.
63. Guzzi F. Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response. / F. Guzzi, D. Zanchetta, P. Cassoni, V. Guzzi, M. Francolini, M. Parenti, B. Chini // Oncogene. - 2002. - № 7. - P. 1658-1667.
64. Cassoni P. Oxytocin and oxytocin receptors in cancer cells and proliferation. / P. Cassoni, A. Sapino, T. Marrocco, B. Chini, G. Bussolati. // J Neuroendocrinol. - 2004. - № 16. - P. 362-364
65. Reversi A. Receptor Signaling in Myoepithelial and Cancer Cells/A. Reversi, P. Cassoni, B. Chini// Journal of Mammary Gland Biology and Neoplasia. - 2005. - № 3. P. 364-367.
66. Rimoldi V. Oxytocin receptor elicits different EGFR/MAPK activation patterns depending on its localization in caveolin-1 enriched domains. / V. Rimoldi, A. Reversi, E. Taverna, P. Rosa, M. Francolini, P. Cassoni, M. Parenti, B. Chini//Oncogene. - 2003. - № 22. - P. 6054-6060.
67. Morita T. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo. / T. Morita, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, S. Mizutani// Int J Cancer. - 2004. - №109. - P. 525-32.
68. Marchio S. Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi’s sarcoma cells. /S. Marchio, L. Primo, M. Pagano, G. Palestro, A. Albini, T. Veikkola, I. Cascone, K. Alitalo, F. Bussolino //J. Biol. Chem. - 1999. - № 274. - P. 27617-27622.
69. Cassoni P. Oxytocin induces proliferation and migration in immortalized human dermal microvascular endothelial cells and human breast tumor-derived endothelial cells. / P. Cassoni, T. Marroco, B. Bussolati, E. Allia, L. Munaron, A. Sapino, G. Bussolati // Mol Cancer Res. - 2006. - №4. - 351-359.
70. Grange C. Isolation and characterization of breast tumor-derived endothelial cells. / C. Grange, B. Bussolati, S. Bruno, A. Sapino, G. Camussi//Oncol Rep. - 2006. - №15. - P. 381-386.
71. Reversi A. The oxytocin receptor antagonist atosiban inhibits cell growth via a “biased agonist” mechanism. /A. Reversi, V. Rimoldi, T. Marrocco// J Biol Chem 2005;№22:16311-8.
72. Thibonnier M. Human Vascular Endothelial Cells Express Oxytocin Receptors / M. Thibonnier, D. M. Conarty, J. A. Preston, C. L. Plesnicher, R. A. Dweik, S. C. Erzurum // Endocrinology. - 1999. - Vol. 140. - № 3. - P. 1301-1309.
73. Otani A. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. /A. Otani, H. Takagi, K. Suzuma, Y. Honda // Circ Res. - 1998. - № 82. - P. 619 - 628.
74. Thibonnier M. Human vascular endothelial cells express oxytocin receptors. / M. Thibonnier, DM. Conarty, J.A. Preston, C.L. Plesnicher, R.A. Dweik, S.C. Erzurum // Endocrinology. - 1999. - № 140. - P. 1301-1309.
75. Cassoni P. Oxytocin is a growth factor for Kaposi’s sarcoma cells: evidence of endocrine-immunological cross-talk./P. Cassoni, A. Sapino, S. Deaglio // Cancer Res. - 2002. - № 62. - P. 2406-2413.
76. Sapino A. Oxytocin receptor within the breast: biological function and distribution. / Sapino A. P. Cassoni, A. Stella, G. Bussolati // Anticancer Res. - 1998. - № 18. - P. 2181-2186.
77. Cassoni P. Oxytocin inhibits the proliferation of MDA-MB231 human breast-cancer cells via cyclic adeno- sine monophosphate and protein kinase A. / P. Cassoni, A. Sapino, N. Fortunati, L. Munaron, B. Chini, G. Bussolati// Int J Cancer. - 1997. - № 72. - P. 340-344.
78. Suzuki Y. Possible role of placental leucine aminopeptidase in the antiproliferative effect of oxytocin in human endometrial adenocarcinoma. / Y. Suzuki, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, S. Nomura, M. Tsujimoto, S. Mizutani//Clin Cancer Res. - 2003. - №9. - P. 1528-1534.
79. Cassoni P. Oxytocin receptors in human adenocarcinomas of the endometrium: Presence and biological significance. / P. Cassoni, E. Fulcheri, ML. Carcangiu, A. Stella, S. Deaglio, G. Bussolati// J Pathol. - 2000. - № 190. - P. 470-477.
80. Cassoni P. Evidence of oxytocin/oxytocin receptor interplay in human prostate gland and carcinomas. / P. Cassoni, T. Marrocco, A. Sapino, E. Allia, G. Bussolati// Int J Oncol. - 2004. - № 25. - P. 899-904.
81. Reversi A. The oxytocin receptor antagonist atosi- ban inhibits cell growth via a “biased agonist” mechanism. / A. Reversi, V. Rimoldi, T. Marrocco, P. Cassoni, G. Bussolati, M. Parenti, B. Chini// J Biol Chem. - 2005. - № 280. - Р. 16311-16318.
82. Cassoni P. Evidence of oxytocin/oxytocin receptor interplay in human prostate gland and carcinomas. / P. Cassoni, T. Marrocco, A. Sapino, E. Allia, G. Bussolati// Int J Oncol. - 2004. - №25. - P. 899-904.
83. Pequeux C. Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway. / C. Pequeux, B.P. Keegan, M.T. Hagelstein, V. Geenen, J.J. Legros, W.G. North.//EndocrRelatCancer. -2004. - № 11. - P. 871-885.
84. Pequeux C. Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through au- tocrine/paracrine signaling. / C. Pequeux, C. Breton, J.C. Hendrick, M.T. Hagelstein, H. Martens, R. Winkler, V. Geenen, J.J. Legros // Cancer Res. - 2002. - №62. - 4623-4629.
85. Cassoni P. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors. / P. Cassoni, A. Sapino, A. Stella, N. Fortunati, G. Bussolati // Int J Cancer. - 1998. - №77. - P. 695-700.
86. Novak J.F. A plasmin-derived hexapeptide from the carboxyl end of osteocalcin counteracts oxytocinmediated growth inhibition of osteosarcoma cells. / J.F. Novak, M.B. Judkins, M.I. Chernin, P. Cassoni, G. Bussolati, J.A. Nitche, S.K. Nishimoto. //Cancer Res. - 2000. - №60. - P. 3470-3476.
87. Thibonnier M. Human vascular endothelial cells express oxytocin receptors. / M. Thibonnier, D.M. Conarty, J.A. Preston, C.L. Plesnicher, R.A. Dweik, S.C. Erzurum // Endocrinology. - 1999. - № 140. -P. 1301- 1305.
88. Cassoni P. Oxytocin is a growth factor for Kaposi’s sarcoma cells: Evi- dence of endocrine-immunological cross-talk. / P. Cassoni, A. Sapino, S. Deaglio, B. Bussolati, M. Volante , L. Munaron, A. Albini, A. Torrisi, G. Bussolati//Cancer Res. - 2002. - № 62. - P. 2406-2413.
89. Cassoni P. Oxytocin is a growth factor for Kaposi’s sarcoma cells: evidence of endocrine-immunological cross-talk. / P. Cassoni, A. Sapino, S. Deaglio, B. Bussolati, M. Volante, L. Munaron, A. Albini, A. Torrisi, G. Bussolati // Cancer Res. - 2002. - №62. - P. 2406-2413.
90. Cassoni P. Oxytocin and oxytocin-analogue F314 inhibit cell proliferation and tumour growth of rat and mammary carcinomas. / P. Cassoni, A. Sapino, M. Papotti, G. Bussolati // Int J Cancer. - 1996. - № 66. - P. 817-820.
91. Bakos J. Effect of oxytocin on neuroblastoma cell viability and growth. /J. Bakos, V. Strbak, N. Ratulovska, Z. Bacova // Cell Mol Neurobiol. - 2012. - №32. - 891-896.
92. Morita T. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo / T. Morita, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, S. Mizutani//Int. J. Cancer. - 2004. - № 109. - P. 525-532
93. Cassoni P. Oxytocin inhibits proliferation of huma n breast cancer cell lines./ P. Cassoni, A. Sapino, F. Negro, G. Bussolati// Virchows Arch. - 1994. - № 425. - P. 467-72.
94. Reversi A. Oxytocin Receptor Signaling in Myoepithelial and Cancer Cells / A. Reversi, P. Cassoni, B. Chini // Journal of Mammary Gland Biology and Neoplasia. - 2005. - № 3. P. 365-369.
95. Cassoni P. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors. / P. Cassoni, A. Sapino, A. Stella, N. Fortunati, and G. Bussolati//Int. J. Cancer. - 1998. - № 77. - P. 695-700.
96. Cassoni P. Antiproliferative effect of oxytocin through specific oxytocin receptors in human neuroblastoma and astrocytoma cell lines./ P. Cassoni, A. Sapino, A. Stella, G. Bussolati// Exp Med Biol. - 1998. - № 449. - P. 245-246.
97. Cassoni P. Presence and significance of oxytocin receptors in human neuroblastomas and glial tumors. / P. Cassoni, A. Sapino, A. Stella, N. Fortunati, G. Bussolati // Int J Cancer. - 1998. - № 77. - P. 695-700.
98. Fay M. J. Oxytocin does not induce a rise in intracellular free calcium in human breast cancer cells. / M.J. Fay, J. Du, K.A. Longo, W.G. North // Res Commun Mol Pathol Pharmacol. - 1999. - № 103. - P. 115-28.
99. Cassoni P. Oxytocin receptors in human adenocarcinoma of the endometrium: presence and biological significance. / P. Cassoni, E. Fulcheri, M.L. Carcangiu, A. Stella, S. Deaglio, G. Bussolati// J Pathol. - 2000. - №190. - P. 470-477.
100. Suzuki Y. Possible role of placental leucine aminopeptidase (P-LAP) in the antiproliferative effect of oxytocin in human endometrial adenocarcinoma. / Y. Suzuki, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, S. Nomura, M. Tsujimoto, S. Mizutani//Clin Cancer Res. - 2003. - № 9. - P. 1528-1534.
101. Mignon C. Assignment of the human membranetype matrix metalloproteinase (MMP14) gene to 14q11-q12 by in situ hybridization. / C. Mignon, A. Okada, M.G. Mattei, P. Basset//Genomics. - 1995. - № 28. - P. 360-361.
102. Dery M-C. Oxytocin Increases Invasive Properties of Endometrial Cancer Cells Through Phosphatidylinositol 3-Kinase/AKT-Dependent Up-Regulation of Cyclooxygenase-1, -2, and X-Linked Inhibitor of Apoptosis Protein / M-C. Dery, P. Chaudhry, V. Leblanc, S. Parent, A. Fortier, E. Asselin // Biology of reproduction. - 2011. - № 85. - P. 1133-1142.
103. Morita T. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo / T. Morita, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, S. Mizutani//Int. J. Cancer. - 2004. - № 109. - P. 525-532.
104. Luo J. Supression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. / J. Luo, D.M. Lubaroff, M. J. Hendrix // Cancer Res. - 1999. -№ 59. - P. 3552-3556.
105. Yano T., Yamasaki H. Regulation of cellular invasion and matrix metaloproteinase activity in HepG2 cell by connexin 26 transfection / T. Yano, H. Yamasaki // Mol Carcinog. - 2001. - V 31. - P 101-109.
106. Kajiyama H. Peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitor of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells / H. Kajiyama, F. Kikkawa, E. Khin, K. Shibata, K. Ino, S. Mizutani // Dipeptidyl Cancer Res. - 2003. - V 63. -P. 2278 - 2283.
107. Morita T. Oxytocin inhibits the progression of human ovarian carcinoma cells in vitro and in vivo / T. Morita, K. Shibata, F. Kikkawa, H. Kajiyama, K. Ino, S. Mizutani// Int J Cancer. - 2004. - V. 109. - P 525-532.
Review
For citations:
Tomchuk O.N. HYPOTHALAMIC NONAPEPTIDE AND CARCINOGENESIS: DISCUSSION QUESTIONS. Morphological newsletter. 2015;23(1):97-105. (In Russ.) https://doi.org/10.20340/mv-mn.2015.0(1):97-105
Views:
329
